Cancer Research

Cancer is a complex disease driven by dynamic genetic and molecular alterations. Advances in multi-omics technologies are enabling researchers to unravel the intricacies of cancer biology and accelerate the development of improved diagnostics and therapies. Next-generation sequencing (NGS) and mass spectrometry provide comprehensive genomic and molecular insights accelerating the search for more effective cancer treatments. Our company provides a comprehensive portfolio of cutting-edge multi-omics services, including next-generation sequencing (NGS) and mass spectrometry, to empower cancer research. We offer cutting-edge multi-omics services, including next-generation sequencing (NGS) and Mass spectrometry, to empower cancer researchers. By gaining a deeper understanding of the complexity of this disease at the DNA, RNA, and protein levels, our multi-omics services help researchers advance prevention, diagnosis, and therapy.

Home

/Cancer Research

Multi-Omics in Cancer Research

DNA sequencing reveals somatic mutations and structural variations that drive cancer initiation and progression. Our whole genome, whole exome, and targeted DNA sequencing services help pinpoint key driver mutations and signatures guiding personalized therapies.

Sequencing across multiple tumor regions highlights genetic diversity and heterogeneity within a tumor. Our NGS solutions enable the characterization of intra-tumor heterogeneity, aiding prognosis and treatment design.

Analysis of circulating tumor DNA (ctDNA) or minimal residual disease (MRD) via targeted NGS provides a non-invasive approach for monitoring cancer recurrence, treatment response, and disease progression. Our ctDNA sequencing services support personalized care.

RNA sequencing uncovers tumor gene expression patterns and signatures associated with specific cancer types or subtypes. This information can be used to develop diagnostic biomarkers, predict treatment response, and identify potential therapeutic targets.

Single-cell RNA sequencing reveals the tumor's immune microenvironment. Our single-cell services elucidate immune profiles for immunotherapy development.
Mass spectrometry quantifies proteins and PTMs across samples. Our proteomic services help discover actionable therapeutic targets and response predictors.

Proteomics can be used to study the abnormal expression of proteins in cancer cells, identify potential therapeutic targets, and uncover new targets by analyzing protein-protein interaction networks.

Metabolomics can be used to study changes in metabolic pathways in cancer cells, identify potential metabolic targets, and reveal new patterns of cancer metabolism by analyzing metabolic data.

NGS Applications

Whole Genome Sequencing

Whole genome sequencing empowers cancer researchers to comprehensively study genetic mutations and identify new therapeutic targets, propelling breakthroughs in precision oncology.

Whole Exome Sequencing

By analyzing the protein-coding regions of DNA, whole exome sequencing enables cancer researchers to efficiently detect mutations in genes that drive tumor growth and metastasis, expediting the development of targeted therapies.

Epigenetics

Epigenetics services enable cancer researchers to identify chemical modifications to DNA that control gene expression, uncovering new mechanisms driving tumor initiation and progression for advanced drug targeting.

RNA Sequencing

RNA sequencing allows cancer researchers to analyze gene expression levels and identify biomarkers involved in tumor progression and metastasis, providing critical genomic insights to develop more effective diagnostic tests and therapies.

Metagenomics

Metagenomics empowers cancer researchers to analyze the collective microbiome genome, helping identify new bacterial drivers of tumor growth and progression for the development of improved probiotic therapies.

Single Cell Sequencing

Single-cell sequencing allows cancer researchers to profile individual cells, revealing tumor heterogeneity and identifying diverse drug-resistant subclones to guide more targeted and effective therapeutic strategies.

Stereo-seq

Life development is a dynamic process in which multiple cell types interact with each other in a three-dimensional space. Therefore, spatial analysis of cell types and their interactions is the basis of developmental research. Spatial transcriptome technology -- Stereo-seq, can map the complex interactions of various cell types during developmental stages at the molecular level, profoundly advancing the field of development with unprecedented precision and complexity.

Mass Spectrometry Applications

Proteomics

Mass spectrometry proteomics services enable cancer researchers to detect biomarkers, comprehend signaling pathways, and identify therapeutic targets by identifying and quantifying proteins and peptides in biological samples.

Metabolomics

Mass spectrometry metabolomics enables cancer researchers to elucidate metabolic pathways, identify diagnostic biomarkers, and reveal the systemic effects of malignancy by profiling the complete complement of small molecule metabolites in biological samples.

Multi-omics

By integrating proteomics, metabolomics, and genomics data from biological samples, mass spectrometry multi-omics services allow cancer researchers to develop a systems-level comprehension of tumors and identify novel diagnostic, prognostic, and therapeutic targets.

If you want more information？
Consult us now!